• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

TERC Gene Record

  • Summary
  • Interactions
  • Claims
  • TERC 7012

    Alternate Names:

    7012
    TELOMERASE RNA COMPONENT
    TERC
    DKCA1
    PFBMFT2
    SCARNA19
    TR
    TRC3
    hTR
    602322
    11727
    ENSG00000270141
    ENSG00000277925
    TELOMERASE-VERT

    Gene Info:

    Gene Biotype LNCRNA
    Gene Biotype MISC_RNA
    (0 More Sources)

    Gene Categories: Category Details

    Publications:

    Kelland, 2000, Telomerase inhibitors: targeting the vulnerable end of cancer?, Anticancer Drugs
    Kiyozuka et al., Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells., Anticancer Res.
  • ZIDOVUDINE   TERC

    Interaction Score: 1.99

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    11036953


    Sources:
    NCI

  • CISPLATIN   TERC

    Interaction Score: 0.43

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    10769656


    Sources:
    NCI

  • Ensembl: ENSG00000270141

    • Version: 101_38

    Alternate Names:
    TERC Ensembl Gene Name

    Gene Info:
    Gene Biotype LNCRNA

    Publications:

  • Ensembl: ENSG00000277925

    • Version: 101_38

    Alternate Names:
    TELOMERASE-VERT Ensembl Gene Name

    Gene Info:
    Gene Biotype MISC_RNA

    Publications:

  • NCI: TERC

    • Version: 14-September-2017

    Alternate Names:

    Gene Info:

    Publications:
    Kiyozuka et al., Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells., Anticancer Res.
    Kelland, 2000, Telomerase inhibitors: targeting the vulnerable end of cancer?, Anticancer Drugs

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21